Letermovir and HCT: too much of a good thing?

Mark R. Schleiss

doi:10.1182/blood.2021011459

Letermovir and HCT: too much of a good thing?

Mark R. Schleiss

Pediatrics - Infectious Disease

Research output: Contribution to journal › Editorial › peer-review

5 Scopus citations

Original language	English (US)
Pages (from-to)	1-2
Number of pages	2
Journal	Blood
Volume	138
Issue number	1
DOIs	https://doi.org/10.1182/blood.2021011459
State	Published - Jul 8 2021

Bibliographical note

Funding Information:
Conflict-of-interest disclosure: The author declares no competing financial interests.

PubMed: MeSH publication types

Editorial
Comment

Access

10.1182/blood.2021011459

OpenUrl availability

Full text

Cite this

@article{53f34546004c4313a229555474da64f9,

title = "Letermovir and HCT: too much of a good thing?",

author = "Schleiss, {Mark R.}",

note = "Funding Information: Conflict-of-interest disclosure: The author declares no competing financial interests.",

year = "2021",

month = jul,

day = "8",

doi = "10.1182/blood.2021011459",

language = "English (US)",

volume = "138",

pages = "1--2",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "1",

}

TY - JOUR

T1 - Letermovir and HCT

T2 - too much of a good thing?

AU - Schleiss, Mark R.

N1 - Funding Information: Conflict-of-interest disclosure: The author declares no competing financial interests.

PY - 2021/7/8

Y1 - 2021/7/8

UR - http://www.scopus.com/inward/record.url?scp=85109464905&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85109464905&partnerID=8YFLogxK

U2 - 10.1182/blood.2021011459

DO - 10.1182/blood.2021011459

M3 - Editorial

C2 - 34236425

AN - SCOPUS:85109464905

SN - 0006-4971

VL - 138

SP - 1

EP - 2

JO - Blood

JF - Blood

IS - 1

ER -

Letermovir and HCT: too much of a good thing?

Bibliographical note

PubMed: MeSH publication types

Access

OpenUrl availability

Other files and links

Cite this